drugset / Trial / NCT00856960

The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)

NCT00856960

Phase 1 Completed 12 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindTreatment

Summary

This study will evaluate the effect of Aliskiren and Losartan on renal blood flow using PAH clearance, PC MRA and ASL MRI methodologies.

Timeline

Start
2010-01
Primary completion
2010-03
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aliskiren Small molecule 150 mg
Comparator Aliskiren Small molecule 600 mg
Comparator Losartan Other / unclassified 100 mg

Indications